Persistent Fungal Mortality in the United States Following the COVID-19 Pandemic Peak, 2022-2025
Public Health Reports® · 19.11.2026
DOI: 10.1177/00333549261502697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Reports®, online erschienen am 19.11.2026. Verfasst von Meagan K. Andrews und 6 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objectives
Fungal infection–associated deaths increased in the United States during the COVID-19 pandemic, but mortality patterns after the pandemic peak are not well-characterized. We analyzed national mortality data to assess whether fungal mortality remained elevated during 2022-2025 and to describe demographic, geographic, pathogen-specific, and underlying cause-of-death patterns after the COVID-19 pandemic peak.
Methods
We analyzed National Vital Statistics System multiple-cause-of-death data for 2022-2025. We defined fungal deaths as deaths with a fungal pathogen listed as an underlying or contributing cause of death and summarized deaths by year, month, pathogen, COVID-19 association, underlying cause of death, demographic characteristics, and US Census division. We used 2018-2019 (prepandemic) and 2021 (peak) as reference periods for selected comparisons.
Results
During 2022-2025, a total of 30 225 fungal deaths occurred (annual average = 7556). The annual age-adjusted mortality rate per 100 000 population increased from 1.2 in 2018-2019 to 1.5 in 2020 and 1.9 in 2021, and remained between 1.8 and 1.9 during 2022-2025. COVID-19–associated fungal deaths declined after early 2022, but overall fungal mortality remained stable. During 2022-2025, the most common underlying causes of death among fungal deaths were malignant neoplasms, HIV disease, and diseases of the heart; the most commonly specified pathogens were Candida and Aspergillus . Mortality rates varied by age, sex, race and ethnicity, and region.
Conclusions
Fungal mortality remained elevated after the COVID-19 pandemic peak despite declines in COVID-19–associated fungal deaths. Continued efforts to monitor fungal disease–related mortality are important to inform efforts to enhance diagnostic capacity and surveillance to better characterize and ultimately reduce the impact of fungal diseases.
Zitieren
APA
Andrews, M. K., Edwards, J. A., Ahmad, F. B., Cisewski, J. A., Rossen, L. M., Toda, M., & Gold, J. A. (2026). Persistent Fungal Mortality in the United States Following the COVID-19 Pandemic Peak, 2022-2025. Public Health Reports®. https://doi.org/10.1177/00333549261502697
Vancouver
Andrews MK, Edwards JA, Ahmad FB, Cisewski JA, Rossen LM, Toda M, et al. Persistent Fungal Mortality in the United States Following the COVID-19 Pandemic Peak, 2022-2025. Public Health Reports®. 2026. doi:10.1177/00333549261502697
BibTeX
@article{Andrews2026,
author = {Andrews, Meagan K. and Edwards, Johnathan A. and Ahmad, Farida B. and Cisewski, Jodi A. and Rossen, Lauren M. and Toda, Mitsuru and Gold, Jeremy A.W.},
title = {Persistent Fungal Mortality in the United States Following the COVID-19 Pandemic Peak, 2022-2025},
journal = {Public Health Reports®},
year = {2026},
doi = {10.1177/00333549261502697}
}
EUVIMED